Ann Pharmacol Pharm | Volume 2, Issue 7 | Review Article | Open Access

Safety a Major Concern with Neurotherpeutic in Traumatic Brain Injury

Chaudhary M^*

Department of Pharmacology, Venus Medicine Research Centre, Baddi, India

^*Correspondance to: Chaudhary M 

Fulltext PDF

Abstract

Traumatic brain injury is one of the leading causes of death worldwide. Over the past several decades, numerous experimental animal models demonstrated that in addition to the primary physical impact of the injury, TBI leads to progressive pathophysiological changes, resulting in a reduction in brain–blood flow and a decrease in tissue oxygen levels leading to ischemia, subsequent secondary injury, blood–brain barrier breakdown and brain edema.

Citation:

Chaudhary M. Safety a Major Concern with Neurotherpeutic in Traumatic Brain Injury. Ann Pharmacol Pharm. 2017; 2(7): 1075.